Pembroke Pines, Florida — Green Leaf Innovations Inc. pointed to Cuba’s dominant role in premium cigars amid reports of surging global demand and limited supply. Habanos S.A., Cuba’s cigar monopoly, posted $827 million in revenue for 2024, according to industry data, though 2025 figures remain unpublished.

Demand for Cuban cigars has exceeded production for years. Jorge Pérez Martell, Habanos commercial vice president, stated that client needs go unmet. The U.S. embargo blocks all sales to American markets, leaving supply tight elsewhere. China ranks as Habanos’ top buyer.

Green Leaf, a Florida corporation, specializes in marketing and distributing handmade premium cigars. It sources brands from Estelí, Nicaragua, crafted by the Mederos family—third-generation Cuban makers tracing heritage to the 1800s. The lineup features CUBANACAN, MEDEROS, TABACALERA SERRANO, MAL.CRI.AO and COCOA. Products reach U.S. cigar lounges, smoke shops, convenience stores and vape shops, plus international outlets.

Cuba’s tobacco regions and cultivation methods underpin its global prestige. Officials at the company said they track regulatory and economic changes on the island that could reshape trade. Easing restrictions might open doors to Cuban tobacco in new areas. Supply chains could link up more tightly. Domestic firms might form partnerships abroad.

Competition in premium cigars would ramp up. Product variety could grow. Investments in farming, processing, distribution and branding might follow. Cuban leaf’s unique traits could alter prices, brand strategies and market positions, Green Leaf executives noted.

No deals, pacts or operations tied to Cuba have been revealed. The firm stresses compliance and careful review of trends. Geopolitical shifts factor into its planning as it chases growth targets.

Habanos controls output tightly. Officials could ramp supply to favored markets if desired. That use mutes revenue figures’ weight, company comments suggest.

Green Leaf pushes quality to aficionados while aiming to boost shareholder returns. Visit www.greenleafinnovation.com or follow @otcgrlf on X for updates. Investor contacts include Ryan Medico at (800) 303-6268 or [email protected].

The release carries forward-looking statements under securities laws. Actual outcomes hinge on market uptake, rivals, rules, funding and economy. Management assumes no duty to revise them unless required.